XBiotech

NASDAQ XBIT
$8.31 -0.30 -3.61%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

252.93M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

52.91M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.49
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

30.44M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

107.75 %

Upcoming events XBiotech

All events
No upcoming events scheduled

Stock chart XBiotech

Stock analysis XBiotech

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-10.30 27.22
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.16 3.54
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.48 9.69
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
5.59 -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-11.22 13.82

Price change XBiotech per year

12.20$ 21.00$
Min Max

Summary analysis XBiotech

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure XBiotech

Revenue and net income XBiotech

All parameters

About company XBiotech

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and True Human COVID-19 therapy for treating the COVID-19 mutant virus. In addition, the company provides clinical trial contract research operations to conduct two large, double-blind placebo-controlled Phase II clinical studies. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Address:
5217 Winnebago Lane, Austin, TX, United States, 78744
Company name: XBiotech
Issuer ticker: XBIT
ISIN: CA98400H1029
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2015-04-15
Sector: Healthcare
Industry: Biotechnology
Site: https://www.xbiotech.com

On which stock exchange are XBiotech (XBIT) stocks traded?

XBiotech (XBIT) stocks are traded on NASDAQ.

What is the ticker of XBiotech stocks (XBIT)?

The stock ticker of XBiotech’s stocks or in other words, the code is XBIT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does XBiotech (XBIT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, XBiotech (XBIT) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are XBiotech (XBIT) stocks traded?

XBiotech (XBIT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of XBiotech (XBIT) stocks today?

The current price of XBiotech stocks on 11.05.2024 is 8.31 dollars. per share.

What is the dynamics of XBiotech (XBIT) stocks from the beginning of the year?

XBiotech (XBIT) quotes have increased by 91.47% from the beginning of the year up to 8.31 dollars. per 1 stocks.

How much did XBiotech (XBIT) stocks increase in мае 2024?

This month XBiotech (XBIT) quotes have increased by 1.84% to 8.31 dollars. per share.

How much are XBiotech (XBIT) stocks worth?

Today, on October, 11.05.2024 XBiotech’s (XBIT) stocks cost 8.31 dollars..

What is the market capitalization of XBiotech (XBIT)?

Capitalization is the market value of XBiotech (XBIT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of XBiotech (XBIT) is estimated at about 252931171 dollars.